Concepedia

Immune Privilege Exploitation

Immune Privilege Exploitation is an immune evasion strategy in which parasites selectively colonize or persist within immunologically specialized host tissues—such as the central nervous system, testes, or eyes—where immune surveillance and inflammatory responses are constitutively attenuated to prevent collateral damage, thereby leveraging the physiological constraints of these privileged sites to avoid detection and destruction by adaptive immunity.

6

Publications

181

Citations

63

Authors

32

Institutions

Publications per year

2017–2026

2

Parents

Publications

6

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy

Chen Yang, Haigang Geng, Xupeng Yang et al. · Cancer Cell · 2024 · 68 citations

, , +16

Targeting Immune Privilege to Prevent Pathogenic Neovascularization

Jayeeta Roychoudhury, John M. Herndon, Jiyi Yin et al. · Investigative Ophthalmology & Visual Science · 2010 · 38 citations · Full text

, , +17

Up-Regulation by Ammonium Trichloro(Dioxoethylene-0,0′) Tellurate (AS101) of Fas/Apo-1 Expression on B16 Melanoma Cells: Implications for the Antitumor Effects of AS101

Yona Kalechman, Gideon Strassmann, Michael Albeck et al. · The Journal of Immunology · 1998 · 30 citations

, , +15

Suppression of Neovascularization of Donor Corneas by Transduction with Equine Infectious Anemia Virus-Based Lentiviral Vectors Expressing Endostatin and Angiostatin

Maria A. Parker, Jessica Bellec, Trevor J. McFarland et al. · Human Gene Therapy · 2014 · 18 citations

, , +17

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Li Yang Tan, Grace Cunliffe, Michael Patrick Hogan et al. · Frontiers in Immunology · 2024 · 18 citations · Full text

, , +17

1–5 of 6

Authors

63

  1. HF
    Hao Feng

    Hunan Normal University, China

    1 publications · 68 citations

    1

    h-index

  2. CZ
    Chuchen Zhu

    Sun Yat-sen University, China

    1 publications · 68 citations

    1

    h-index

  3. LX
    Lei Xu

    Chongqing Medical University, China

    1 publications · 68 citations

    1

    h-index

  4. SZ
    Si‐Si Zhang

    Wenzhou Medical University, China

    1 publications · 68 citations

    1

    h-index

  5. HW
    Hui Wang

    Chinese Academy of Sciences, China

    1 publications · 68 citations

    1

    h-index

1–5 of 63

Institutions

32

  1. The University of Texas Southwestern Medical Center

    Dallas, United States

    1 h-index

    2 publications

    20 citations

  2. Methodist Hospital

    Sacramento, United States

    1 h-index

    4 publications

    68 citations

  3. Shanghai Jiao Tong University

    Shanghai, China

    1 h-index

    20 publications

    1.4K citations

  4. Oncode Institute

    Utrecht, Netherlands

    1 h-index

    1 publications

    68 citations

  5. Bar-Ilan University

    Ramat Gan, Israel

    1 h-index

    3 publications

    90 citations

  6. The Netherlands Cancer Institute

    Amsterdam, The Netherlands

    1 h-index

    1 publications

    68 citations

  7. Union Hospital

    Shatin, China

    1 h-index

    1 publications

    68 citations

  8. Oxford BioMedica (United Kingdom)

    Oxford, United Kingdom

    1 h-index

    4 publications

    72 citations

1–8 of 32

Venues

  1. Cancer Cell

    1 publications · 68 citations

    1

    h-index

  2. Investigative Ophthalmology & Visual Science

    IOVS · 1 publications · 38 citations

    1

    h-index

  3. International Journal of Molecular Sciences

    IJMS · 1 publications · 17 citations

    1

    h-index

  4. Cell & Bioscience

    1 publications · 10 citations

    1

    h-index

  5. Human Gene Therapy

    1 publications · 18 citations

    1

    h-index

1–5